Hangzhou Combak Hospital

Hangzhou Combak Hospital is a specialized oncology facility based in Hangzhou, China, that integrates clinical care with advanced biotechnological research. The hospital focuses on the development and administration of innovative immunotherapies, particularly chimeric antigen receptor T-cell (CAR-T) and natural killer (NK) cell therapies for refractory cancers. It conducts numerous clinical trials targeting solid tumors such as liver, pancreatic, and gastric cancers. By combining clinical practice with cell therapy R&D, the institution aims to provide precision medicine solutions for patients with advanced-stage malignancies. The hospital operates GMP-compliant facilities for the production of cell-based biologics, facilitating rapid translation from bench to bedside.